🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. SHP643

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. SHP681

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. SPD422

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. SPD489 (Lisdexamfetamine dimesylate)

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  5. SPD503

    Takeda

    Healthy

    phase 1 small molecule completed

    2 trials

  6. SPD544

    Takeda

    ADHD

    phase 1 small molecule completed

    1 trial

  7. SSP-002358

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  8. SSP-004184

    Takeda

    Impaired Renal Function

    phase 1 small molecule completed

    1 trial

  9. SSP-004184

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  10. SSP-004184AQ

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  11. SSP-004184SS

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  12. SYR-472

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  13. Sapanisertib

    Takeda

    Non-hematologic Malignancy

    phase 1 small molecule completed

    1 trial

  14. Scopolamine

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  15. Simvastatin

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  16. Soticlestat

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  17. Soticlestat

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    4 trials

  18. Soticlestat 300 mg

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. TAK-004

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. TAK-007

    Takeda

    Refractory Lupus Nephritis

    phase 1 mab terminated

    1 trial

  21. TAK-020

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  22. TAK-020 Captisol Oral Solution

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  23. TAK-058

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. TAK-058

    Takeda

    Schizophrenia

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources